canwellbiotech.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * | ||
Meta Tags
| Title | 康威（广州）生物科技有限公司 |
| Description | 康威（广州）生物科技有限公司-响应式 |
| Keywords | 康威（广州）生物科技有限公司-响应式 |
Server Information
| WebSite | |
| Host IP | 43.129.158.133 |
| Location | Japan |
Related Websites
| Site | Rank |
More to Explore
canwellbiotech.com Valuation
|
US$1,061
Last updated: 2023-05-19 02:53:56
canwellbiotech.com has Semrush global rank of 0. canwellbiotech.com has an estimated worth of US$ 1,061, based on its estimated Ads revenue. canwellbiotech.com receives approximately 122 unique visitors each day. Its web server is located in Japan, with IP address 43.129.158.133. According to SiteAdvisor, canwellbiotech.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,061 |
| Daily Ads Revenue | US$0 |
| Monthly Ads Revenue | US$29 |
| Yearly Ads Revenue | US$352 |
| Daily Unique Visitors | 8 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| canwellbiotech.com. | A | 600 | IP: 43.129.158.133 |
| canwellbiotech.com. | NS | 21600 | NS Record: f1g1ns2.dnspod.net. |
| canwellbiotech.com. | NS | 21600 | NS Record: f1g1ns1.dnspod.net. |
| canwellbiotech.com. | MX | 600 | MX Record: 5 mxbiz1.qq.com. |
| canwellbiotech.com. | MX | 600 | MX Record: 10 mxbiz2.qq.com. |
| canwellbiotech.com. | TXT | 600 | TXT Record: v=spf1 include:spf.mail.qq.com ~all |
HtmlToTextCheckTime:2023-05-19 02:53:56
| 康威（广州）生物科技有限公司 HOME ABOUT US PROFILE TEAM EXPERIENCE PRODUCT R & D PIPELINE GLOBAL COLLABORATION NEWS COMPANY NEWS MEDIA REPORTS JOIN US CONTACT US EN 中文 繁 英 简 --> 感恩 实干 团队精神 View more > ABOUT CANWELL Delicate to bringing novel medicines to cancer patients around the world CANWELL BIOTECH Ltd., founded in June 2018, is an innovative drug research and development company, focusing on the development and commercialization of anti-tumor First-in-Class and Best-in-Class immunotherapies. By harnessing both innate and adaptive immune responses against tumor cells. CanWell is building its immuno-oncology product platforms through 2 lead programs, CAN1012, a TLR7 agonist, and DPV-001, a dendritic cell targeted cancer vaccine. RESEARCH AND DEVELOPMENT PLATFORM View more > NEWS CENTER View more > ABOUT US PROFILE TEAM EXPERIENCE PRODUCT R & D PIPELINE GLOBAL COLLABORATION NEWS COMPANY NEWS MEDIA REPORTS JOIN US CONTACT US 02032038762 ©2019 - 2022 UnitedStar (5189) All rights |
HTTP Headers
HTTP/1.1 200 OK Date: Sun, 21 Aug 2022 08:16:01 GMT Server: Apache/2 Expires: Thu, 19 Nov 1981 08:52:00 GMT Cache-Control: no-store, no-cache, must-revalidate Pragma: no-cache Set-Cookie: PHPSESSID=bf528514f4dd54262f95714de93d2b23; path=/ Upgrade: h2,h2c Connection: Upgrade Vary: User-Agent Content-Type: text/html; charset=utf-8 |
canwellbiotech.com Whois Information
Domain Name: CANWELLBIOTECH.COM Registry Domain ID: 2336850789_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.paycenter.com.cn Registrar URL: http://www.xinnet.com Updated Date: 2021-11-23T03:26:29Z Creation Date: 2018-11-26T02:44:00Z Registry Expiry Date: 2022-11-26T02:44:00Z Registrar: Xin Net Technology Corporation Registrar IANA ID: 120 Registrar Abuse Contact Email: supervision@xinnet.com Registrar Abuse Contact Phone: +86.4008182233 Domain Status: ok https://icann.org/epp#ok Name Server: F1G1NS1.DNSPOD.NET Name Server: F1G1NS2.DNSPOD.NET DNSSEC: unsigned >>> Last update of whois database: 2022-08-21T08:15:49Z <<< |